Dalbavancin: a new option for systemic treatment of Gram-positive endogenous endophthalmitis? Hamon A, Benaboud S, Anjou M, Thoreau B, et al. J Antimicrob Chemother 2023;78:3005-3006.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hamon A, Benaboud S, Anjou M, Thoreau B, et al. Dalbavancin: a new option for systemic treatment of Gram-positive endogenous endophthalmitis? J Antimicrob Chemother 2023;78:3005-3006.
PMID: 37812460